Vicki L. Sato
Currently, Vicki L. Sato is Non-Executive Chairman of Denali Therapeutics, Inc. and Non-Executive Chairman at Vir Biotechnology, Inc. Dr. Sato is also on the board of BorgWarner, Inc., Bristol-Myers Squibb Co., Prize4Life, Inc. and Peer Health Exchange and Member-Overseers Board at The Isabella Stewart Gardner Museum, Inc.nShe previously occupied the position of President of Vertex Pharmaceuticals, Inc., Vice President-Research at Biogen, Inc., Business Advisor at Atlas Venture, Inc., Member-Scientific Counselors Board at The Broad Institute, Inc., Advisor at BioVentures Investors, Professor at Harvard University and Professor at Harvard Business School.nVicki L. Sato received a doctorate and an undergraduate degree from Harvard University and an undergraduate degree from Radcliffe College.
|04/24/2019||2,985||Award at $43.55 per share.||129,996|
|04/25/2018||2,457||Award at $52.91 per share.||129,999|
|04/26/2017||2,991||Award at $41.12 per share.||122,989|
|04/27/2016||3,131||Award at $39.28 per share.||122,985|
|04/29/2015||1,887||Award at $60.95 per share.||115,012|